Profile
David Bearman served as a Director of AtheroGenics, Inc. from November 2002 to September 9, 2008.
Previously, he was Senior Vice President and Chief Financial Officer of Home Depot Supply from March 2006 to 2007, having served in a similar capacity with Hughes Supply Company, Inc. from March 2003 to March 2006.
From 1998 to 2001, Mr. Bearman served as Senior Vice President and Chief Financial Officer of NCR Corporation and as a Member of the NCR Executive Committee.
From 1989 to 1998, he served as Executive Vice President and Chief Financial Officer of Cardinal Health, Inc.
Former positions of David Bearman
| Companies | Position | End |
|---|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Director/Board Member | 08/09/2008 |
Hughes Supply, Inc.
 Hughes Supply, Inc. Wholesale DistributorsDistribution Services Hughes Supply, Inc. provides electrical, plumbing, fixtures and supplying services. Its services include building materials, electric utilities, irrigation systems and fire protection. The company was founded in 1928 and is headquartered in Orlando, FL. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Hughes Supply, Inc.
Hughes Supply, Inc. Wholesale DistributorsDistribution Services Hughes Supply, Inc. provides electrical, plumbing, fixtures and supplying services. Its services include building materials, electric utilities, irrigation systems and fire protection. The company was founded in 1928 and is headquartered in Orlando, FL. | Distribution Services |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
- Stock Market
- Insiders
- David Bearman
